Hosted by the AACR, NCI, and EORTC, the Molecular Targets and Cancer Therapeutics conference was held from October 11-15, 2023 in Boston and attracted over 1,800 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, the impact of new discoveries in cellular and molecular biology, and early clinical trials. Innovative, targeted therapeutics are discovered through the rapid advances in our understanding of the molecular basis of cancer. Continued clinical progress in cancer treatments is accomplished through the conduct of translational research projects, efficient new drug development, and the execution of large, prospective, randomized, multicenter cancer clinical trials. This requires a joint and global approach to exchange information early in the development process.

THANK YOU TO OUR SUPPORTERS

SUPPORTERS
Boehringer Ingleheim
Bristol Myers Squibb
Janssen
Sanofi

PROFESSIONAL EDUCATION GRANTS
Amgen
Novartis
Pfizer

POSTER SESSION SUPPORTER